Boron-containing small molecules as anti-inflammatory agents

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Boron containing doai

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C558S288000, C546S284100, C546S290000

Reexamination Certificate

active

08039450

ABSTRACT:
Compounds and methods of treating anti-inflammatory conditions are disclosed.

REFERENCES:
patent: 2260336 (1941-10-01), Prescott et al.
patent: 3873279 (1975-03-01), Singer
patent: 4602011 (1986-07-01), West et al.
patent: 4716035 (1987-12-01), Sampathkumar
patent: 4766113 (1988-08-01), West et al.
patent: 4894220 (1990-01-01), Nabi et al.
patent: 5348947 (1994-09-01), Patel et al.
patent: 5348948 (1994-09-01), Patel et al.
patent: 5591731 (1997-01-01), Kennedy et al.
patent: 5668258 (1997-09-01), Stolowitz
patent: 5688928 (1997-11-01), Stolowitz
patent: 5831045 (1998-11-01), Stolowitz et al.
patent: 5880188 (1999-03-01), Austin et al.
patent: 5962498 (1999-10-01), Driedger et al.
patent: 6083903 (2000-07-01), Adams et al.
patent: 6306628 (2001-10-01), Rothschild et al.
patent: 6369098 (2002-04-01), Pershadsingh et al.
patent: 6521619 (2003-02-01), Link et al.
patent: 6800645 (2004-10-01), Cox et al.
patent: 6855848 (2005-02-01), Scherer et al.
patent: 7169603 (2007-01-01), Hedley et al.
patent: 7217701 (2007-05-01), Mikoshiba et al.
patent: 7390806 (2008-06-01), Lee et al.
patent: 7465836 (2008-12-01), Lee et al.
patent: 7582621 (2009-09-01), Baker et al.
patent: 7767657 (2010-08-01), Baker et al.
patent: 7816344 (2010-10-01), Baker et al.
patent: 2002/0028831 (2002-03-01), Manley
patent: 2002/0161230 (2002-10-01), Meudt et al.
patent: 2003/0032673 (2003-02-01), Nagy
patent: 2004/0077601 (2004-04-01), Adams et al.
patent: 2004/0224923 (2004-11-01), Lee et al.
patent: 2004/0259842 (2004-12-01), Mikoshiba et al.
patent: 2005/0054644 (2005-03-01), Lee et al.
patent: 2005/0125852 (2005-06-01), Caenepeel et al.
patent: 2005/0239170 (2005-10-01), Hedley et al.
patent: 2006/0009386 (2006-01-01), Stossel et al.
patent: 2006/0222671 (2006-10-01), Weidner
patent: 2006/0234981 (2006-10-01), Baker et al.
patent: 2007/0155699 (2007-07-01), Baker et al.
patent: 2007/0286822 (2007-12-01), Sanders et al.
patent: 2007/0293457 (2007-12-01), Baker et al.
patent: 2009/0227541 (2009-09-01), Baker et al.
patent: 2010/0256092 (2010-10-01), Xia et al.
patent: 0969531 (2000-01-01), None
patent: 1155698 (2001-11-01), None
patent: 1 444 981 (2004-08-01), None
patent: WO 9533754 (1995-05-01), None
patent: WO 9622023 (1996-07-01), None
patent: WO 9812206 (1998-03-01), None
patent: WO 0044387 (2000-08-01), None
patent: WO 0075142 (2000-12-01), None
patent: WO 0149303 (2001-07-01), None
patent: WO 0244184 (2002-06-01), None
patent: WO 03033002 (2003-04-01), None
patent: WO 03059916 (2003-07-01), None
patent: WO 2004056322 (2004-07-01), None
patent: WO 2005013892 (2005-02-01), None
patent: WO 2006007384 (2006-01-01), None
patent: WO 2006062731 (2006-06-01), None
patent: WO 2006079843 (2006-08-01), None
patent: WO 2006089067 (2006-08-01), None
patent: WO 2007022437 (2007-02-01), None
patent: WO 2007078340 (2007-07-01), None
patent: WO 2007095638 (2007-08-01), None
patent: WO 2007146965 (2007-12-01), None
patent: WO 2008157726 (2008-12-01), None
patent: WO 2009111676 (2009-09-01), None
patent: WO 2009014309 (2009-11-01), None
patent: WO 2010028005 (2010-03-01), None
patent: WO 2010045503 (2010-04-01), None
patent: WO 2010045505 (2010-04-01), None
Austin, et al., “Oxaboroles and Salts and their Use of Biocides for Plastics”, CAS, vol. 124, pp. 234-024, (1996).
Bailey, et al., “Boron-Containing Antibacterial Agents: Effects on Growth and Morphology of Bacteria Under Various Culture Conditions,” Antimicrobial Agents and Chemotherapy, 17(04):549-553, (Apr. 1980).
Baker, et al., “Discovery of New Boron-Containing Antifungal Agent, 5-Fluoro-1,3-dihydro-1-hydroxy-2, 1-benzoxaborole (AN2690) for Potential Treatment of Onychomoycosis”, Journal of Medicinal Chemistry, vol. 49, No. 15; pp. 4447-4450, (Jul. 27, 2006).
Brown, et al., “Chiral Synthesis Via Organoboranes. 35. Simple Procedures for the Efficient Recycling of the Terpenyl Chiral Auxiliaries and Convenient Isolation of the Homoallylic Alcohols in Asymmetric Allyl- and Crotylboration of Aldehydes,” J. Org. Chem., vol. 57, No. 24; pp. 6608-6614, (1992).
Cairns, et al., “Derivatives of 1,4-Xylene-2,5-diboronic acid and 1,4-xylene-2-boronic acid”, J. Org. Chem. vol. 29; pp. 2810-2812, (1964).
Chander, et al. “Prevalence of Fungal Corneal Ulcers in Northern India”, Infections, vol. 22, No. 3; pp. 207-209, (1994).
Chemical Abstracts Registry No. 845302-09-2, Entered STN Mar. 11, 2005.
Cui, et al., “Organoboron Compounds with an 8-Hydroxyquinolato Chelate and Its Derivatives: Substituent Effects on Structures and Luminescence,” Inorganic Chemistry, vol. 44, No. 03; pp. 601-609, (Feb. 7, 2005).
Dale, et al., “Substituted Styrenes VIII Syntheses and some Reactions of the Vinylbenzeneboronic Acids” J. Org. Chem. vol. 27; pp. 2598-2603, (1962).
Denis, “Pharmacology 1104 Lecture: Drug Classifications & Characteristics of Antimicrobials” (2003).
Farfan, et al., “Through-Bond Modulation on N-B Ring Formation Shown by NMR and X-Ray Diffraction Studies of Borate Derivatives of Pyridyl Alcohols,” J. Chem. Soc. Perkin Trans., vol. 2; pp. 527-532 (1992).
Ferrer, Targeting Aminocytl-tRNA Synthetases for the Treatment of Fungal Infections, Drug News Perspective, vol. 19, No. 6; pp. 347-348, (Jul./Aug. 2006).
Fungicide: Definition from Answer.com, (1998).
Grassberger, et al., “Degradation of 1,2-dihydro-1-hydroxy-2-(organosulfonyl)2,3,1-benzodiasaborines and -thieno[3,2-d][1,,3]diazaborines in Alkaline Aqueous Solutions”, Liebigs Annalen Der Chemie, vol. 4; pp. 683-688, (1985).
Guo-Zheng, et al., “Single Site Transarylation of 2,2′-Dimetalized-1,1′-Binaphthyl to Aminocloroborates and Synthesis of 2-Binaphthyl Boron Compounds,” Youji Huaxue/Organic Chemistry, Science Press, vol. 16, No. 02; pp. 139-144, (1996) (English Abstract).
Haynes, et al., “Arylboronic Acids VIII. Reactions of boronphthalide” J. Org. Chem. vol. 29, No. 11; pp. 3229-3233, (1964).
Hauck, et al., “Preparation and Anticonvulsant Activity of Some Arydialkkylsuccinimides” Research Lab of Parke Davis Co. (1967).
He, et al., “Small-Molecule Inhibition of TNF-alpha”, Science, vol. 310, No. 5750; pp. 1022-1025, (Nov. 11, 2005).
Lampe, et al., “Synthesis and Protein Kinase Inhibitory Activity of Balanol Analogues with Modified Benzophenone Subunits”, J. Med. Chem., vol. 45; pp. 2624-2643, (2002).
Lennarz, et al., “Arylboronic Acids. IV. Reactions of Boronophthalide” J. Am. Chem. Soc. vol. 82; pp. 2172-2175, (1960).
Li, et al., “An Improved Protocol for Preparation of 3-Pyridyl- and Some Arylboronic Acids”, J. Org. Chem., vol. 67; pp. 5394-5397, (2002).
Koster, et al., “Cyclisierugen von Bor-Stickstoff-Verbindugen in der Hietz” Liebigs Ann. Chem., vol. 720; pp. 23-31, (1968).
Koster, et al., “Boron Compounds, XXXIX. Alkenoxy(diorgany)boranes Substituted at the Alkeonxy Group from 2-methylacrolein and triorganylboranes,” Justus Liebigs Annalen Der Chemie, No. 06; pp. 1116-1134, (1976).
McMillin, et al., “Systemic Aspects of Psoriasis: An Intergrative Model Based on Intestinal Etiology”, Int. Med. vol. 2, Issue 2/3, (1999).
Moeder, et al., “Kinetic Analysis of the Asymmetric Amplification exhibited by B-chlorodiisopinocampheylborane,” Journal of Physical Organic Chemistry, vol. 17, No. 4; pp. 317-324, (Apr. 2004).
Morissette, et al., “High-throughput Crystallization: Polymorphs, Salts, Co-Crystals and Solvates of Pharmaceutical Solids”, Advanced Drug Delivery Reviews, vol. 56; pp. 273-300, (2004).
Patani, et al., “Bioterrorism: A Rational Approach to Drug Design”, Chem. Rev., vol. 96; pp. 3147-3176 (1996).
Qin, et al., “Luminescent Organoboron Quinolate Polymers,” Journal of the American Chemical Society, vol. 126, No. 22; pp. 7015-7018, (Jun. 9, 2004).
Rock, et al., “An Antifungal Agents Inhibits Aminoacyl-tRNA Synthetase by Trapping tRNA in the Editing

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Boron-containing small molecules as anti-inflammatory agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Boron-containing small molecules as anti-inflammatory agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Boron-containing small molecules as anti-inflammatory agents will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4280905

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.